Literature DB >> 31695373

Fabrication Of Gold Nanoparticles In Absence Of Surfactant As In Vitro Carrier Of Plasmid DNA.

Rania S Abdel-Rashid1, Samia M Omar1,2, Mohammed S Teiama1, Ahmed Khairy3, Mohamed Magdy4, Badawi Anis5.   

Abstract

PURPOSE: This work aimed to synthesize surfactant-free AuNPs for targeted delivery of plasmid DNA encoded p53 gene and to avoid conventional production method of Gold nanoparticles (AuNPs) which may adversely affect the final shape, diversity, and size due to accumulation of the formulated surfactant - gold complex to the surface.
METHODS: The AuNPs were fabricated using seeded-growth method with L-Cystine methyl ester hydrochloride as capping agent, then loaded with plasmid DNA encoded p53 gene. The resultant AuNPs and AuNPs-p53 complex were evaluated for physical characteristics and morphology. Confirmation of complex formation was performed using gel electrophoresis. Furthermore, the efficient delivery and cytotoxicity behavior of the encoded gene were examined on both healthy lung cells (WI38) and cancerous lung cells (A549).
RESULTS: L-cysteine methyl ester hydrochloride AuNPs showed acceptable physical characteristics (30 nm, +36.9 mv, and spherical morphology). P53 attachment to AuNPs was confirmed by gel electrophoresis. The RT-PCR proved the overexpression of p53 by the fabricated AuNPs-p53 complex. The high percentage of cell viability in normal lung cell line (WI 38) proved the safety of L-cysteine methyl ester functionalized AuNPs. Additionally, the apoptotic effect due to expression of p53 gene loaded on AuNPs was only prominent in lung cancer cell line (A549), revealing selectivity and targeting efficiency of anticancer AuNPs-p53 complex.
CONCLUSION: AuNPs can be considered as a potential delivery system for effective transfection of plasmid DNA which can be used for successful treatment of cancer.
© 2019 Abdel-Rashid et al.

Entities:  

Keywords:  gene delivery; gold nanoparticles; human lung cancer; plasmid DNA; transfection

Mesh:

Substances:

Year:  2019        PMID: 31695373      PMCID: PMC6815217          DOI: 10.2147/IJN.S226498

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  41 in total

Review 1.  Effect of surface properties on nanoparticle-cell interactions.

Authors:  Ayush Verma; Francesco Stellacci
Journal:  Small       Date:  2010-01       Impact factor: 13.281

2.  Preparation of chitosan-plasmid DNA nanoparticles encoding interleukin-12 and their expression in CT-26 colon carcinoma cells.

Authors:  Somayeh Hallaj-Nezhadi; Hadi Valizadeh; Siavoush Dastmalchi; Behzad Baradaran; Mohammad Barzegar Jalali; Faramarz Dobakhti; Farzaneh Lotfipour
Journal:  J Pharm Pharm Sci       Date:  2011       Impact factor: 2.327

Review 3.  p53 in survival, death and metabolic health: a lifeguard with a licence to kill.

Authors:  Flore Kruiswijk; Christiaan F Labuschagne; Karen H Vousden
Journal:  Nat Rev Mol Cell Biol       Date:  2015-07       Impact factor: 94.444

4.  Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size.

Authors:  Eunkeu Oh; James B Delehanty; Kim E Sapsford; Kimihiro Susumu; Ramasis Goswami; Juan B Blanco-Canosa; Philip E Dawson; Jessica Granek; Megan Shoff; Qin Zhang; Peter L Goering; Alan Huston; Igor L Medintz
Journal:  ACS Nano       Date:  2011-07-20       Impact factor: 15.881

5.  Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship.

Authors:  Jiaqi Lin; Hongwu Zhang; Zhen Chen; Yonggang Zheng
Journal:  ACS Nano       Date:  2010-09-28       Impact factor: 15.881

Review 6.  Biogenic gold nanoparticles: As a potential candidate for brain tumor directed drug delivery.

Authors:  R M Tripathi; Archana Shrivastav; B R Shrivastav
Journal:  Artif Cells Nanomed Biotechnol       Date:  2014-03-03       Impact factor: 5.678

7.  Surface and size effects on cell interaction of gold nanoparticles with both phagocytic and nonphagocytic cells.

Authors:  Xiangsheng Liu; Nan Huang; Huan Li; Qiao Jin; Jian Ji
Journal:  Langmuir       Date:  2013-07-11       Impact factor: 3.882

8.  Mechanisms of quantum dot nanoparticle cellular uptake.

Authors:  Leshuai W Zhang; Nancy A Monteiro-Riviere
Journal:  Toxicol Sci       Date:  2009-05-04       Impact factor: 4.849

Review 9.  Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma.

Authors:  Kevin G Chen; Julio C Valencia; Jean-Pierre Gillet; Vincent J Hearing; Michael M Gottesman
Journal:  Pigment Cell Melanoma Res       Date:  2009-08-29       Impact factor: 4.693

10.  A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer.

Authors:  Mengmeng Dong; Jiawen Chen; Jiayuan Zhang; Xiao Liang; Jiebing Yang; Dan Li; Quanshun Li
Journal:  Int J Nanomedicine       Date:  2019-02-13
View more
  4 in total

Review 1.  In vivo gene delivery mediated by non-viral vectors for cancer therapy.

Authors:  Reza Mohammadinejad; Ali Dehshahri; Vijay Sagar Madamsetty; Masoumeh Zahmatkeshan; Shima Tavakol; Pooyan Makvandi; Danial Khorsandi; Abbas Pardakhty; Milad Ashrafizadeh; Elham Ghasemipour Afshar; Ali Zarrabi
Journal:  J Control Release       Date:  2020-07-04       Impact factor: 9.776

2.  Development of Dual Functional Nucleic Acid Delivery Nanosystem for DNA Induced Silencing of Bcl-2 Oncogene.

Authors:  Somayeh Karimi; Mohamad Hassan Fouani; Ahmad Moshaii; Maryam Nikkhah; Saman Hosseinkhani; Reza Sheikhnejad
Journal:  Int J Nanomedicine       Date:  2020-03-10

Review 3.  Gold nanoparticle‑mediated delivery of paclitaxel and nucleic acids for cancer therapy (Review).

Authors:  Zhiguang Wang; Jianyu Dong; Qiaojiajie Zhao; Ying Ying; Lijie Zhang; Junrong Zou; Shuqi Zhao; Jiuju Wang; Yuan Zhao; Shanshan Jiang
Journal:  Mol Med Rep       Date:  2020-10-11       Impact factor: 2.952

Review 4.  Gold-Polymer Nanocomposites for Future Therapeutic and Tissue Engineering Applications.

Authors:  Panangattukara Prabhakaran Praveen Kumar; Dong-Kwon Lim
Journal:  Pharmaceutics       Date:  2021-12-28       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.